Single-Agent Rituximab for Primary CNS Lymphoma During Pregnancy As a Bridge to Definitive Management

被引：12
|
作者：
Burnette, Brian L. [1 ]
Jentoft, Mark A. [1 ]
Porrata, Luis F. [1 ]
Boyce, Thomas G. [1 ]
Witzig, Thomas E. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 07期
关键词：
DEFERRED RADIOTHERAPY; BREAST-CANCER; CHEMOTHERAPY; METHOTREXATE;
D O I：
10.1200/JCO.2012.47.6994
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E14 / E17
页数：4
相关论文
共 50 条
  • [31] Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma
    Lucroy, MD
    Phillips, BS
    Kraegel, SA
    Simonson, ER
    Madewell, BR
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1998, 12 (05): : 325 - 329
  • [32] SAFETY AND FEASIBILITY OF RAPID RITUXIMAB INFUSIONS IN PATIENTS WITH PRIMARY CNS LYMPHOMA
    Modelevsky, Lisa
    Tizon, Richard
    Garonce, Rachel
    Reiss, Samantha
    Kaley, Thomas
    NEURO-ONCOLOGY, 2016, 18 : 1 - 1
  • [33] POTENTIAL EFFECTIVE CONSOLIDATION THERAPY WITH SINGLE AGENT IBRUTINIB FOR A CASE WITH PRIMARY CNS LYMPHOMA AFTER INITIAL HD-MTX AND RITUXIMAB INDUCTION THERAPY
    Du, Steven
    Ko, Uvin
    Bota, Daniela
    Kong, Xiao-Tang
    NEURO-ONCOLOGY, 2021, 23 : 111 - 111
  • [34] Phase I Study of Single Agent Ibrutinib in Recurrent/Refractory Primary and Secondary CNS Lymphoma
    Christian, Grommes
    Thomas, Kaley
    Abdel-Wahab, Omar
    Omuro, Antonio M.
    Ingo, Mellinghoff
    DeAngelis, Lisa
    BLOOD, 2015, 126 (23)
  • [35] Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma:: Results of a phase II trial of rituximab
    Davis, TA
    White, CA
    Grillo-López, AJ
    Velásquez, WS
    Link, B
    Maloney, DG
    Dillman, RO
    Williams, ME
    Mohrbacher, A
    Weaver, R
    Dowden, S
    Levy, R
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1851 - 1857
  • [36] Single-agent management of diabetes and ischemia reperfusion injury
    Williams, Richard D.
    Denlinger, Chadrick E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (03): : 711 - 712
  • [37] Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience
    Tuncer, Samuray
    Tanyildiz, Burak
    Basaran, Mert
    Buyukbabani, Nesimi
    Dogan, Oner
    CURRENT EYE RESEARCH, 2015, 40 (08) : 780 - 785
  • [38] BevacizumabThrombocytopenia during single-agent therapy: case report
    Reactions Weekly, 2010, 1288 (1) : 9 - 9
  • [39] Single-agent thalidomide induces response in T-cell lymphoma
    Damaj, G
    Bouabdallah, R
    Vey, N
    Bilger, K
    Mohty, M
    Gastaut, JA
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (02) : 169 - 171
  • [40] CYTOSINE-ARABINOSIDE AS A SINGLE-AGENT FOR THE INDUCTION OF REMISSION IN CANINE LYMPHOMA
    RUSLANDER, D
    MOORE, AS
    GLIATTO, JM
    LHEUREUX, D
    COTTER, SM
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1994, 8 (04) : 299 - 301
12345